晚期艾滋病毒疾病的护理标准:对撒哈拉以南非洲六个国家艾滋病毒治疗指南的审查。

IF 2.1 4区 医学 Q3 INFECTIOUS DISEASES AIDS Research and Therapy Pub Date : 2023-11-23 DOI:10.1186/s12981-023-00581-5
Thomas C Scheier, Nabila Youssouf, Mosepele Mosepele, Cecilia Kanyama, Olukemi Adekanmbi, Sulaiman Lakoh, Conrad K Muzoora, Graeme Meintjes, Dominik Mertz, John W Eikelboom, Sean Wasserman
{"title":"晚期艾滋病毒疾病的护理标准:对撒哈拉以南非洲六个国家艾滋病毒治疗指南的审查。","authors":"Thomas C Scheier, Nabila Youssouf, Mosepele Mosepele, Cecilia Kanyama, Olukemi Adekanmbi, Sulaiman Lakoh, Conrad K Muzoora, Graeme Meintjes, Dominik Mertz, John W Eikelboom, Sean Wasserman","doi":"10.1186/s12981-023-00581-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The World Health Organization (WHO) recommends an evidence-based package of care to reduce mortality and morbidity among people with advanced HIV disease (AHD). Adoption of these recommendations by national guidelines in sub-Saharan Africa is poorly documented. We aimed to review national guidelines for AHD management across six selected countries in sub-Saharan Africa for benchmarking against the 2021 WHO recommendations.</p><p><strong>Methods: </strong>We reviewed national guidelines from six countries participating in an ongoing randomized controlled trial recruiting people with AHD. We extracted information addressing 18 items of AHD diagnosis and management across the following domains: [1] Definition of AHD, [2] Screening, [3] Prophylaxis, [4] Supportive care, and [5] HIV treatment. Data from national guideline documents were compared to the 2021 WHO consolidated guidelines on HIV and an agreement score was produced to evaluate extent of guideline adoption.</p><p><strong>Results: </strong>The distribution of categories of agreement varied for the national documents. Four of the six countries addressed all 18 items (Malawi, Nigeria, Sierra Leone, Uganda). Overall agreement with the WHO 2021 guidelines ranged from 9 to 15.5 out of 18 possible points: Malawi 15.5 points, Nigeria, and Sierra Leone 14.5 points, South Africa 13.5 points, Uganda 13.0 points and Botswana with 9.0 points. Most inconsistencies were reported for the delay of antiretroviral therapy (ART) in presence of opportunistic diseases. None of the six national guidelines aligned with WHO recommendations around ART timing in patients with tuberculosis. Agreement correlated with the year of publication of the national guideline.</p><p><strong>Conclusion: </strong>National guidelines addressing the care of advanced HIV disease in sub-Saharan Africa are available. Besides optimal timing for start of ART in presence of tuberculosis, most national recommendations are in line with the 2021 WHO standards.</p>","PeriodicalId":7503,"journal":{"name":"AIDS Research and Therapy","volume":"20 1","pages":"83"},"PeriodicalIF":2.1000,"publicationDate":"2023-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668471/pdf/","citationCount":"0","resultStr":"{\"title\":\"Standard of care in advanced HIV disease: review of HIV treatment guidelines in six sub-Saharan African countries.\",\"authors\":\"Thomas C Scheier, Nabila Youssouf, Mosepele Mosepele, Cecilia Kanyama, Olukemi Adekanmbi, Sulaiman Lakoh, Conrad K Muzoora, Graeme Meintjes, Dominik Mertz, John W Eikelboom, Sean Wasserman\",\"doi\":\"10.1186/s12981-023-00581-5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The World Health Organization (WHO) recommends an evidence-based package of care to reduce mortality and morbidity among people with advanced HIV disease (AHD). Adoption of these recommendations by national guidelines in sub-Saharan Africa is poorly documented. We aimed to review national guidelines for AHD management across six selected countries in sub-Saharan Africa for benchmarking against the 2021 WHO recommendations.</p><p><strong>Methods: </strong>We reviewed national guidelines from six countries participating in an ongoing randomized controlled trial recruiting people with AHD. We extracted information addressing 18 items of AHD diagnosis and management across the following domains: [1] Definition of AHD, [2] Screening, [3] Prophylaxis, [4] Supportive care, and [5] HIV treatment. Data from national guideline documents were compared to the 2021 WHO consolidated guidelines on HIV and an agreement score was produced to evaluate extent of guideline adoption.</p><p><strong>Results: </strong>The distribution of categories of agreement varied for the national documents. Four of the six countries addressed all 18 items (Malawi, Nigeria, Sierra Leone, Uganda). Overall agreement with the WHO 2021 guidelines ranged from 9 to 15.5 out of 18 possible points: Malawi 15.5 points, Nigeria, and Sierra Leone 14.5 points, South Africa 13.5 points, Uganda 13.0 points and Botswana with 9.0 points. Most inconsistencies were reported for the delay of antiretroviral therapy (ART) in presence of opportunistic diseases. None of the six national guidelines aligned with WHO recommendations around ART timing in patients with tuberculosis. Agreement correlated with the year of publication of the national guideline.</p><p><strong>Conclusion: </strong>National guidelines addressing the care of advanced HIV disease in sub-Saharan Africa are available. Besides optimal timing for start of ART in presence of tuberculosis, most national recommendations are in line with the 2021 WHO standards.</p>\",\"PeriodicalId\":7503,\"journal\":{\"name\":\"AIDS Research and Therapy\",\"volume\":\"20 1\",\"pages\":\"83\"},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2023-11-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668471/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"AIDS Research and Therapy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1186/s12981-023-00581-5\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"AIDS Research and Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12981-023-00581-5","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

摘要

背景:世界卫生组织(世卫组织)推荐一套循证护理方案,以降低晚期艾滋病毒感染者(AHD)的死亡率和发病率。撒哈拉以南非洲国家准则采纳这些建议的记录很少。我们的目标是审查撒哈拉以南非洲六个选定国家的AHD管理国家指南,以对照世卫组织2021年建议制定基准。方法:我们回顾了参与正在进行的招募AHD患者的随机对照试验的六个国家的国家指南。我们提取了以下领域的18项AHD诊断和管理信息:[1]AHD的定义,[2]筛查,[3]预防,[4]支持性护理和[5]HIV治疗。将国家指南文件的数据与2021年世卫组织艾滋病毒综合指南进行了比较,并编制了一个一致性评分,以评估指南的采用程度。结果:国家文件的协议类别分布存在差异。六个国家中有四个国家(马拉维、尼日利亚、塞拉利昂、乌干达)处理了所有18个项目。总体上对世卫组织2021年指南的认同程度在9至15.5分(总分18分)之间:马拉维15.5分,尼日利亚和塞拉利昂14.5分,南非13.5分,乌干达13.0分,博茨瓦纳9.0分。大多数不一致的报告是由于存在机会性疾病而延迟抗逆转录病毒治疗(ART)。六项国家指南中没有一项与世卫组织关于结核病患者抗逆转录病毒治疗时机的建议一致。协议与国家指南出版的年份相关。结论:撒哈拉以南非洲已经有了关于晚期艾滋病毒疾病护理的国家指南。除了结核病患者开始抗逆转录病毒治疗的最佳时机外,大多数国家建议都符合世卫组织2021年标准。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Standard of care in advanced HIV disease: review of HIV treatment guidelines in six sub-Saharan African countries.

Background: The World Health Organization (WHO) recommends an evidence-based package of care to reduce mortality and morbidity among people with advanced HIV disease (AHD). Adoption of these recommendations by national guidelines in sub-Saharan Africa is poorly documented. We aimed to review national guidelines for AHD management across six selected countries in sub-Saharan Africa for benchmarking against the 2021 WHO recommendations.

Methods: We reviewed national guidelines from six countries participating in an ongoing randomized controlled trial recruiting people with AHD. We extracted information addressing 18 items of AHD diagnosis and management across the following domains: [1] Definition of AHD, [2] Screening, [3] Prophylaxis, [4] Supportive care, and [5] HIV treatment. Data from national guideline documents were compared to the 2021 WHO consolidated guidelines on HIV and an agreement score was produced to evaluate extent of guideline adoption.

Results: The distribution of categories of agreement varied for the national documents. Four of the six countries addressed all 18 items (Malawi, Nigeria, Sierra Leone, Uganda). Overall agreement with the WHO 2021 guidelines ranged from 9 to 15.5 out of 18 possible points: Malawi 15.5 points, Nigeria, and Sierra Leone 14.5 points, South Africa 13.5 points, Uganda 13.0 points and Botswana with 9.0 points. Most inconsistencies were reported for the delay of antiretroviral therapy (ART) in presence of opportunistic diseases. None of the six national guidelines aligned with WHO recommendations around ART timing in patients with tuberculosis. Agreement correlated with the year of publication of the national guideline.

Conclusion: National guidelines addressing the care of advanced HIV disease in sub-Saharan Africa are available. Besides optimal timing for start of ART in presence of tuberculosis, most national recommendations are in line with the 2021 WHO standards.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
AIDS Research and Therapy
AIDS Research and Therapy INFECTIOUS DISEASES-
CiteScore
3.80
自引率
4.50%
发文量
51
审稿时长
16 weeks
期刊介绍: AIDS Research and Therapy publishes articles on basic science, translational, clinical, social, epidemiological, behavioral and educational sciences articles focused on the treatment and prevention of HIV/AIDS, and the search for the cure. The Journal publishes articles on novel and developing treatment strategies for AIDS as well as on the outcomes of established treatment strategies. Original research articles on animal models that form an essential part of the AIDS treatment research are also considered
期刊最新文献
Compliance with reporting standards in Mobile App interventions for ART Adherence among PLHIV. Traditional complementary and alternative medicine (TCAM) use among PLHIV on antiretroviral medication. Clustering affordable care act qualified health plans to understand how and where insurance facilitates or impedes access to HIV prevention. Prevalence, associated factors, barriers and facilitators for oral HIV self-testing among partners of pregnant women attending antenatal care clinics in Wakiso, Uganda. The role of CREB and MAPK signaling pathways in ATLL patients.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1